Literature DB >> 1501641

Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.

A H Fairlamb1, N S Carter, M Cunningham, K Smith.   

Abstract

An arsenical resistant cloned line of Trypanosoma brucei brucei was derived from a parent sensitive clone by repeated selection in vivo with the pentavalent melaminophenyl arsenical, sodium melarsen. The melarsen-resistant line was tested in vivo in mice against a range of trypanocidal compounds and found to be cross-resistant to the trivalent arsenicals, melarsen oxide, melarsoprol and trimelarsen (33, 67 and 122-fold, respectively). A similar pattern of cross-resistance was found in vitro using a spectrophotometric lysis assay (greater than 200-fold resistance to melarsen oxide and greater than 20-fold resistance to both trimelarsen and melarsoprol). Both lines were equally sensitive to lysis by the lipophilic analogue phenylarsine oxide in vitro, suggesting that the melamine moiety is involved in the resistance mechanism. Although trypanothione has been reported to be the primary target for trivalent arsenical drugs [1], levels of trypanothione and glutathione were not significantly different between the resistant and sensitive lines. Statistically significant differences were found in the levels of trypanothione reductase (50% lower in the resistant clone) and dihydrolipoamide dehydrogenase (38% higher in the resistant clone). However, the Km for trypanothione disulphide, the Ki for the competitive inhibitor Mel T (the melarsen oxide adduct with trypanothione) and the pseudo-first order inactivation rates with melarsen oxide were the same for trypanothione reductase purified from both clones. The melarsen-resistant line also showed varying degrees of cross-resistance to the diamidines: stilbamidine (38-fold), berenil (31.5-fold), propamidine (5.7-fold) and pentamidine (1.5-fold). Cross-resistance correlates with the maximum interatomic distance between the amidine groups of these drugs and suggests that the diamidines and melaminophenyl arsenicals are recognised by the same transport system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501641     DOI: 10.1016/0166-6851(92)90023-d

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  19 in total

1.  Predominance of duplicative VSG gene conversion in antigenic variation in African trypanosomes.

Authors:  N P Robinson; N Burman; S E Melville; J D Barry
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Immunobiology of African trypanosomes: need of alternative interventions.

Authors:  Toya Nath Baral
Journal:  J Biomed Biotechnol       Date:  2010-02-23

3.  In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.

Authors:  C J Bacchi; R Brun; S L Croft; K Alicea; Y Bühler
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Modulation of mitochondrial electrical potential: a candidate mechanism for drug resistance in African trypanosomes.

Authors:  J M Wilkes; W Mulugeta; C Wells; A S Peregrine
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis.

Authors:  Antoaneta Y Sokolova; Susan Wyllie; Stephen Patterson; Sandra L Oza; Kevin D Read; Alan H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

6.  Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome.

Authors:  Mark R Ariyanayagam; Sandra L Oza; Maria Lucia S Guther; Alan H Fairlamb
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.

Authors:  C J Bacchi; H C Nathan; N Yarlett; B Goldberg; P P McCann; A Sjoerdsma; M Saric; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

8.  Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.

Authors:  R Mukhopadhyay; S Dey; N Xu; D Gage; J Lightbody; M Ouellette; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10

10.  Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution.

Authors:  B J Berger; A H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.